This trial is a post-marketing trial, since the blood-sugar-lowering drug has been available in the US since 2013
Czech Journal of Food Sciences, 35 (5), 456
Reductions in fat-free muscle volume were small and within expected ranges based on UK Biobank reference data
District Court in New Jersey, challenges advertisements comparing
The cost-benefit argument A strong argument has been made that subsidising these drugs will save money in the long term by reducing cases of obesity and heart disease
Launched by Commissioner Martin Makary in June, the program enables the agency to award vouchers to drug developers whose work addresses a health crisis in the United States, delivers more innovative cures, addresses unmet public health needs, and increases domestic drug manufacturing as a national security issue